Project

General

Profile

Obj. 3: Retention and VL Sup #640

3.7: Line-list and track all patients eligible for VL testing and systematically request VL tests

Added by Gilles about 1 year ago. Updated about 1 year ago.

Status:
New
Priority:
Normal
Assignee:
-
Start date:
04/01/2023
Due date:
09/30/2023 (about 12 months late)
% Done:

0%

Estimated time:
(Total: 0.00 h)
Spent time:
(Total: 6.00 h)
Additional Details
Rate $ Hourly
Additional Assignee

Subtasks

Obj. 3: Retention and VL Sup #793: Train and mentor service providers on monitoring of patients with low level viremia and management of patients with high VLNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #803: Organize one semi-annual mentoring session per site for service providers in all the 96 sites on monitoring of patients with low level viremia and management of patients with high VL including the use of treatment failure algorithm and improve documentatiNew05/01/202305/31/2023

Actions
Obj. 3: Retention and VL Sup #804: Regional training of service providers of all PEPFAR supported sites on monitoring and management of patients with HVL (doctors, Major, retention APSs)New07/01/202307/31/2023

Actions
Obj. 3: Retention and VL Sup #805: Use the opportunity of data review meeting on viral load thematic to mentor service providers on monitoring of patients with low level viremia and management of patients with high VL, with the support of the SOP produced based on national guidelinesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #794: Line-list and track all patients eligible for VL testing and systematically request VL tests (update daily)New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #806: Print & distribute the list of clients eligible to VL to APS, CBO, dispensers and doctors for identification and viral load sample collection. New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #807: Develop and implement a pre-clinic checklist to routinize client file preparation before each clinic and to clearly define interventions for each client, including VLNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #808: Organize Sample collection everyday in the facility or in specific days in CBO, to help improve VL coverage in less time. Ensure APS calls eligible patients with future appointments to come for sample collection before their appointment date (client on MNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #809: Create a template or a line-list of all eligible clients by APS cohort with their VL due dates for effective follow-up in all the facilities of both regionNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #810: Organize one mentoring session or onsite refresher training per facility during a coordination meeting for clinicians/care providers to ensure they know when it is time for another VL testNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #811: Use of a daily monitoring VL collection tool by APS based on their daily and monthly targets for collectionNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #795: Review VL flow to reduce missed opportunities for sample collection. New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #813: Use a list of eligibles clients with an APS stationed at the reception desk of the CTA/UPEC unit to screen and track clients especially those receiving family dispensation to ease their collection at the community. New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #814: Rotate APS at each facility reception desk of each UPEC/CTA to screen all clients eligible for VL collection. of and teach them on methods of adequate screening. New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #815: Reorganise patient flow such that the data team can ensure those to be dispensed are actually not missed for VL collection.New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #816: Continue the annotation of VL RDV dates on the client's prescription forms to help remind them of their next VL sample collection dates. While coaching the prescriptors to always put on renewed prescriptions.New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #817: Ensure the effective use of VL prescription forms to help reduce missed opportunities. New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #796: Optimize patient flow in the facility New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #818: Optimize patient flow in the facility with the triage system in all dispensation points for VL eligibility checkNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #819: Organize weekly feedback of VL reference labs to facilities concerning the samples collected with results still awaited, through the bikersNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #797: Operationalize a system of immediate notification for HVL resultsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #820: Provide monthly communication credit to reference lab majors to facilitate the early communication of HVL results between reference lab and health facility to help reduce turnaround time for the start of EAC sessions. New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #821: Engage APS by cohort for tracking and documentation of EAC sessions to be done for all clientsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #822: Support phone calls to clients for EAC enrolment, follow-up 2nd and 3rd EAC done by phone New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #823: Engage Viral load focal point at facility level to receive and do the triage of HVL results to be distributed to each APS by cohort, with immediate return of the client with HVL from CBO to facilitiesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #798: Improve documentation of VL results in patient filesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #824: Support the photocopy of all VL results once they are received from the reference labs and distribute it by cohort for each APS to document in patient file in all the facilitiesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #825: Continue the color coding system to identify service needs for each client along the VL cascade. New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #826: Organize onsite chart review with care providers (Doctor, Major and APS) targeting VL documentation of results to improve patient outcome, depending on needsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #799: Establish ‘modified’ viremia clinics in supported facilities using VL champions and Focal pointsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #827: Establish dedicated clinic days with fewer patients (mainly those with HVL) once a month in selected supported facilitiesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #828: Enhance triage and patient flow to improve waiting time of client with HVL using Identified case managers who provide care navigation and appointment supportNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #829: Strengthen multidisciplinary team (MDT) approach: clear roles and responsibilities, case discussions together, in selected sitesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #830: Optimize (individual or collective) counseling to HVL clients by qualified adherence counselors (trained APS or care providers) with timely repeat VL tests following enhanced adherence counseling and prompt 2nd line ART initiationNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #831: Organize one mentoring session per semester per or refresher training on the management of patients with low viremia and patients with HVL including proper documentation practices for VL activitiesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #832: Pair all VL suppressed adolescents (champions) identiified with HVL adolescents to allow peer support and counsellingNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #833: Renforcement of effective start of viremia clinics twice monthly in all facilities. With programmed training on how a veremia clinic should be runNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #834: Use APS having more VL suppressed clients for tiers 1 & 2 to mentor the other champions on sites (tiers 3 & 4)New04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #835: Ensure proper use of the EAC forms and HVL registers in all supported facilitiesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #800: Facilitate ongoing mentorship and supportive supervision by providers from high performing ART sites to support low performing sitesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #836: Identification of peer APS retention and CBO dispensers mentors by districtsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #837: Organize Cross mentoring sessions to sites and CBO with retention and VL collection challengesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #801: Strengthen use of HVL registers to track EAC and clients with high VLNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #838: Conduct data review meetings on HVL cascade by cohort in all supported facilitiesNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #839: Organize onsite mentoring of care providers on documentation and implementation of EAC sessionsNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #802: Ensure early identification of treatment failureNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #840: Identify clients supected to have treatment failureNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #841: Transport support for the transfert of sample collected for resistance test from the reference laboratry to CIRCBNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #842: Collaboration with Bikers and CRHISS Foundation ( in the East) for the transportation of sample collected for resitance test from the supported facilities to reference laboratory in the East and Center RegionNew04/01/202309/30/2023

Actions
Obj. 3: Retention and VL Sup #843: Train and mentor health care providers on the interpretation of resistance test resultsNew05/01/202305/30/2023

Actions

No data to display

Also available in: Atom PDF